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Background: Although tuberculosis (TB) incidence has been decreasing in the European Union/European Economic
Area (EU/EEA) in the last decades, specific subgroups of the population, such as migrants, remain at high risk of TB.
This study is based on the report ‘Key Infectious Diseases in Migrant Populations in the EU/EEA’ commissioned by
The European Centre for Disease Prevention and Control. Methods: We collected, critically appraised and
summarized the available evidence on the TB burden in migrants in the EU/EEA. Data were collected through:
(i) a comprehensive literature review; (ii) analysis of data from The European Surveillance System (TESSy) and (iii)
evidence provided by TB experts during an infectious disease workshop in 2012. Results: In 2010, of the 73 996 TB
cases notified in the EU/EEA, 25% were of foreign origin. The overall decrease of TB cases observed in recent years
has not been reflected in migrant populations. Foreign-born people with TB exhibit different socioeconomic and
clinical characteristics than native sufferers. Conclusion: This is one of the first studies to use multiple data sources,
including the largest available European database on infectious disease notifications, to assess the burden and
provide a comprehensive description and analysis of specific TB features in migrants in the EU/EEA. Strengthened
information about health determinants and factors for migrants’ vulnerability is needed to plan, implement and
evaluate targeted TB care and control interventions for migrants in the EU/EEA.
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Introduction
Tuberculosis (TB) is a major public health concern. In 2013, therewere an estimated 8.9 million (range 8.6–9.4 million) incident
cases of TB globally, corresponding to 126 cases per 100 000
population. Moreover, TB was responsible for 1.5 million deaths.1
The greatest numbers of TB cases occur in low-income settings,
predominantly Asia (56%) and Africa (29%).1
The World Health Organization (WHO) estimates that 4% of TB
cases in 2013 occurred in the WHO European Region, with Eastern
Europe particularly affected by the TB epidemic.1 Within the
European Union/European Economic Area (EU/EEA), TB notifica-
tion rates have been declining over the last decades, reaching 14.2 per
100 000 population in 2011.2 Despite this decline, specific subgroups
of the population, such as homeless people, migrants, people living in
urban settings and prisoners, remain at an increased risk of acquiring
TB infection and developing active disease; this representing a
challenge for TB control programmes.3,4 In particular, in many EU/
EEA settings the contribution of cases among foreign-born individ-
uals to the total TB burden is increasing each year.5 The pathways
through which migrants are at higher risk for both transmission of TB
infection and development of disease might include coming from
high TB burden countries as well as being more exposed to socioeco-
nomic and behavioural risk factors in their host countries. Migrants
settled in host countries may also face legal, cultural, linguistic and
socioeconomic barriers to healthcare that can delay TB diagnosis and
limit access to health education and effective treatment.6,7
Few data are available on the TB burden in migrant populations in
the EU/EEA. However, understanding the diverse health needs of
migrants is becoming increasingly important, not least due to the
rising proportion of migrants in the EU/EEA. From 1990 to 2010,
the proportion of foreign-born individuals in the EU/EEA increased
from 6.9 to 9.7% of the total population.8 In 2011, it is estimated that
48.9 million foreign-born residents were residing in the EU, with 32.4
million born outside it.8 To address the data gaps on infectious
diseases among migrant populations, in 2012 the European Centre
for Disease Prevention and Control (ECDC) commissioned a report
titled ‘Key Infectious Diseases in Migrant Populations in the EU/
EEA’. This article is based on that report and collects, critically
appraises and summarizes the best available evidence on the burden
of TB in migrant populations in the EU/EEA. Specific objectives are:
(i) to estimate the burden of TB in foreign-born populations when
compared with native populations in EU/EEA countries based on
notification data, highlighting geographical patterns and time
trends; (ii) to establish the burden of TB in migrants by gender, age
group and country of origin as well as other relevant subgroups and
(iii) to identify limitations of the available data and information gaps.
Methods
To meet the specified aim and objectives, we retrieved data using three
methods: (i) a comprehensive review of the literature, (ii) analysing
relevant data from The European Surveillance System (TESSy) and
(iii) evidence provided by infectious disease and migration experts at
an ECDC meeting on migrant health held in 2012.9
Comprehensive literature review
The literature search was conducted using Medline, Web of Science
and The Cochrane Library as well as 18 websites of key organizations.
 The European Journal of Public Health Advance Access published December 13, 2014
It sought literature published up to September 2012. Additional
records were retrieved through the citations of papers retrieved and
consultation with experts in the field. Articles were considered for
inclusion if they: (i) were descriptive and analytic observational
studies, experimental studies, narrative reviews, systematic reviews
and meta-analyses, guidelines or policy documents; (ii) were
published after 2006; (iii) were published in English; (iv) included
data from the EU/EEA. The search strategy was built using a combin-
ation of key words for the three main axes of the research question: (a)
the selected disease: TB; (b) the study population: migrant popula-
tions; (c) study setting: the EU/EEA. For the PubMed search, free text
terms were combined with Medical Subject Heading (MeSH) terms.
Eligibility assessment for inclusion was performed in a two-step
process independently by two reviewers, by first screening titles and
abstracts and then full-text papers. Disagreements between reviewers
were resolved by discussion. Data relevant to answer the study
questions (detailed in the ‘specific objective’ earlier) were extracted
to a predefined form. High priority was given to recent nationally
representative studies and large population-based studies. No
minimum sample size was selected but small hospital-based studies
were only included if no other data were available and their limita-
tions in terms of generalizability were reported.
Analysis of TESSy data
TESSy is a metadata-driven platform managed by ECDC to collect,
analyse and disseminate data on 53 communicable diseases and
conditions under surveillance. All EU/EEA-Member States report
data to TESSy. For the purpose of this study, we extracted data on
TB from the TESSy database—including notification data, demo-
graphic and clinical characteristics as well as data relevant to the
migration status of affected cases. Migrant status was determined
by extracting data on the ‘country of birth’ variable.10
Case-based TB surveillance data were extracted from TESSy on 2
February 2012. Data for the years 2000-10 were analysed. Differences
in reporting between countries were analysed and, where the data
allowed it, trends over time were described. The TESSy database was
interrogated to conduct further analyses on migrant populations not
available in the ECDC surveillance report2 and used to complement
it. All analyses were carried out in MS Excel 2013.
Evidence provided by infectious disease and migration
experts at an ECDC meeting on migrant health
In October 2012, the ECDC and the Portuguese National Institute of
Health Dr. Ricardo Jorge (INSA) co-hosted an expert meeting on
infectious diseases and migration in Lisbon, Portugal. Infectious
disease and public health experts from Canada, France, Germany,
Greece, Italy, Luxembourg, Spain, UK and USA participated as
country representatives. They provided detailed country-level data
on infectious disease surveillance, notification and reporting systems
for migrant populations. For the purpose of this study, data relevant
to TB in migrants were retrieved and reported.
Results
TB surveillance and reporting in the EU/EEA: focus on
migrant populations
Since 2008, the collection and analysis of TB surveillance data in
Europe has been conducted jointly by the ECDC and the WHO
Regional Office for Europe (WHO/Europe). Data are collected
from national surveillance institutions,10 and data from EU/EEA
countries are validated by ECDC.4 In 2011, 25 countries in the
EU/EEA reported information on origin of TB cases by the place
of birth of those affected (born in the country vs. being of foreign
origin) and five used the classification of citizenship of the respective
country (citizen vs. non-citizen).2 Denmark and the Netherlands
reported the birth place of cases’ parents; in Denmark, the geograph-
ical origin for TB cases under 26 years of age is classified according
to parents’ place of birth (e.g. native-born cases under 26 years of
age whose parents were born outside Denmark are classified as
foreign-born cases).10–12 Data completeness for geographical origin
of cases varies widely between countries.2,10
Our analysis of the TESSy data showed that up to 2001 very few
countries reported case-based data on origin of TB cases to ECDC.
After 2002 an increasing number of countries started to report on
origin of TB cases; in the 2002-10 period, origin was known for
nearly 80% of the TB cases.
Burden of TB in the EU/EEA: focus on migrant
populations
In the EU/EEA in 2010, 54 111 (73.1%) of the 73 996 notified TB
cases were from the EU/EEA (referred to as ‘native’), 1284 (1.7%)
were of unknown origin and 18 601 (25.1%) were of foreign origin.11
The percentage of foreign-origin cases ranged from 0.2% in
Romania to 85.8% in Sweden (table 1).11 In six countries (Cyprus,
Iceland, Malta, the Netherlands, Norway and Sweden), the
percentage of foreign-born subjects among total TB notifications
was >70%, whereas in 11 countries it was >50% (table 1).12 Of all
EU/EEA countries, only Lichtenstein did not provide information
on the origin of TB cases. Overall, the proportion of foreign-origin
cases has been increasing since 2001.12 In 2010, the proportion of
foreign-origin cases among total TB notifications in the EU/EEA was
slightly higher than in 2008 (22.4%)13 and 2007 (21%).4 The overall
decrease of TB cases observed in recent years has not been reflected
in migrant populations. Only six countries (Belgium, Denmark,
Estonia, Germany, Luxemburg and Slovenia) reported a decrease
in TB cases of foreign origin, 11 countries reported an increase in
cases and 10 countries reported no major changes over time.10
Country of origin and sociodemographic
characteristics of foreign-born TB cases
Our analysis of the TESSy data showed that in 2010 the largest share
of foreign-born TB cases were from Asia (34%), followed by Africa
(22%) and other countries of the 53 countries of the WHO
European region (13%). Of the cases coming from the WHO
European region, 12% came from EU-Member States that joined
prior to 2004, 56% came from EU-Member States that joined
between 2004 and 2013 and 32% were from non-EU-Member
States. The country of birth of foreign-born cases was unknown
for 25% of migrant cases. Trends in the origin of foreign-born
cases have been relatively stable over time, with the exception of
an increase in the percentage of unknown country of birth
between 2006 and 2008 (figure 1).
In a study from Italy, the distribution of the geographical origin of
TB cases mirrored the distribution of the geographical origin of
migrant populations in the country.5 In UK, 57% of foreign-born
people with TB reported in 2010 were born in South Asia, 27% in
Sub-Saharan Africa, with other regions accounting for lower per-
centages.14 Data from primary research in the EU/EEA show similar
patterns. In the Netherlands, a recent study identified the main
countries of origin of primary TB cases as Somalia, Morocco and
Turkey15 which are among the main sources of the migrant
population in the country. In Italy, the largest share of foreign-
born TB cases come from the Middle East (36.6%) and Africa
(21.7%) which are common countries of origin for migrants to
Italy.5 Country experts at the Lisbon ‘Migrant health’ workshop
reported that 8.4% of notified TB cases in Germany in 2010 with
known country of birth were born in the Newly Independent States
of the former Soviet Union (NIS: Armenia, Azerbaijan, Belarus,
Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russian Federation,
Tajikistan, Turkmenistan, Ukraine, Uzbekistan and the three Baltic
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States Latvia, Lithuania and Estonia). Other foreign countries
accounted for 36.2% of total TB cases.
TB cases in migrant populations tend to be in younger individuals
than is the case with native citizens.5,15,16 More than half of TB cases
of foreign origin notified in 2011 in the EU/EEA were in young
adults (25-44 years) and 50% of cases of national origin were in
the middle-aged (45-64 years) or elderly categories.4 As seen in the
TESSy data, migrants with TB are 9 years younger (mean age: 37.5
vs. 46.3 years) than native sufferers, with this difference remaining
stable in 2002-10 study period.
In both native and migrant populations, males are more
frequently reported with TB. Overall, in the EU/EEA in 2010, the
male:female sex ratio was 2.0:1 for native TB cases and 1.5:1 for
foreign-born cases (table 1),12 the differences in ratios appears to
be greater in migrants in some EU/EEA countries and less in others.
TB incidence
TB incidence rates among migrants varied across the EU/EEA and in
different study periods but, in the vast majority of EU/EEA
countries, TB incidence in foreign-born populations is higher than
in native populations.15–17 For example, as reported by country
experts at the ‘Migrant Health’ Lisbon workshop,18 national surveil-
lance data from France in 2009 showed that TB incidence in foreign-
born subjects was nearly nine times higher than in subjects born in
France (35.1/100 000 vs. 4.3/100 000). In UK, although the TB
incidence in the foreign-born UK population rose from 75.5/
100 000 population in 2000 to 81.6/100 000 in 2010, it remained
stable at 4/100 000 in the UK-born population during the same
period (figure 2).17 Data from regional and local studies conducted
in the EU/EEA are consistent with national surveillance data.5,16
Analyses of TB incidence trends are not possible using the TESSy
data, as no reliable population denominators for migrants are
available for all EU/EEA-Member States.
TB transmission by origin of cases
Data from the National TB surveillance system in the UK indicate
that 77% of TB cases among foreign-born individuals are diagnosed
2 or more years after arrival in the host country.14 In contrast, sur-
veillance data from France presented during the Lisbon workshop18
highlighted how TB notification rates in foreign-born subjects were
higher in the first 2 years after entering France than later among all
categories of migrants. Similarly, data from Spain reported that, in
urban areas, around 50% of foreign-born TB cases were diagnosed
with TB within the first 2 years after arrival.19 Such differences might
be driven by different underlying TB burdens in countries of origin,
as well as differences in migrants’ networks and exposures to social
and behavioural risk factors in host countries. Several studies from
Spain, Italy, Belgium and the Scandinavian region used both trad-
itional epidemiologic approaches and molecular techniques to study
the transmission dynamics and cluster characteristics of TB cases by
country of origin.16,19–24 There is much heterogeneity among these
studies, showing various degrees of transmission from foreign-born
to native-born populations. The attribution of transmission in
mixed clusters of native-born and foreign-born varies greatly
between studies and countries. In some studies, the reported prob-
ability of TB transmission from foreign-born to native subjects in
mixed clusters was low.16,24,25 For example, data from Germany
show that, in mixed clusters, the probability that cases will be in
foreign-born subjects was estimated at 18.3%.16 Some authors
reported no evidence of significant TB transmission between
native citizens and migrants.16,25 In particular, a large national-rep-
resentative study conducted in Denmark showed that TB transmis-
sion was 2.5 times more likely to occur from Danes to migrants than
vice versa.25 Data from Spain estimated that, in mixed clusters, index
cases were foreign-born in 50% of cases.19
Site of TB disease by origin of cases
Evidence from the UK shows extra-pulmonary TB to be associated
with being of foreign-origin.26 In UK in 2010, 54% of foreign-born
TB cases had extra-pulmonary TB while this percentage was only
31% in UK-born TB cases.14 Surveillance data also indicate that
extra-pulmonary-TB is more frequent in foreign-born subjects
several years after entry to the host country.14 In the Netherlands,
notification data for the period 1993-2001 showed that non-Dutch
nationals were more likely to have extra-pulmonary TB.27 In
particular, during the study period, the absolute number of Dutch
extra-pulmonary TB cases decreased (rate ratio per year: 0.96, 95%
CI: 0.94–0.98), whereas the absolute number of non-Dutch extra-
pulmonary TB cases increased (rate ratio per year: 1.06, 95% CI:
1.04–1.07).27
Table 1 Percentage of migrant TB cases (by country of birth or
citizenship) in the EU/EEA, 2010
Country Criterion Foreign (%) Total N
Austria Citizenship 43.5 688
Belgium Citizenship 54.6 1115
Bulgaria Birthplace 0.1 2649
Cyprus Birthplace 82.0 61
Czech Republic Birthplace 17.3 678
Denmark Birthplace 60.2 359
Estonia Birthplace 17.6 329
Finland Birthplace 32.1 327
France Birthplace 48.3 5116
Germany Birthplace 45.7 4330
Greece Citizenship 47.2 489
Hungary Citizenship 1.2 1741
Iceland Birthplace 72.7 22
Ireland Birthplace 40.0 427
Italy Birthplace 55.7 3249
Latvia Birthplace 6.6 934
Lithuania Birthplace 2.4 1938
Luxembourg Birthplace 58.6 29
Malta Birthplace 78.1 32
Netherlands Birthplace 73.5 1073
Norway Birthplace 85.3 339
Poland Citizenship 0.6 7509
Portugal Birthplace 16.2 2626
Romania Birthplace 0.2 21 078
Slovakia Birthplace 1.8 439
Slovenia Birthplace 23.8 172
Spain Birthplace 32.0 7089
Sweden Birthplace 85.8 675
United Kingdom Birthplace 68.6 8483
Subtotal EU/EEA 25.1 73 996
Figure 1 Notified migrant TB cases by country of birth or citizen-
ship, EU/EEA 2000-10
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Drug resistance by origin of cases
Multi-drug resistant (MDR) TB represents a major public health
concern in Eastern Europe and Central Asia.28,29 Findings from
the literature review showed no clear pattern in risk of drug
resistance between foreign-born and native TB cases. The EU/EAA,
ECDC/WHO surveillance data for the year 2010 reported lower per-
centages of MDR-TB in foreign-origin than in native cases (3.1% vs.
6.8%, respectively).11 Data from our TESSy analysis suggest higher
proportions of MDR-TB in TB cases born in Northern Europe
(13.9%), followed by Central Asia (12.0%), Eastern Europe
(10.7%) and Eastern Asia (3.9%) with a mean MDR-TB
percentage for all regions of 5.3%. However, there are differences
in data completeness: resistance is unknown in 33-35% of cases from
Northern Europe and Central Asia, and in 80% of cases coming
from Eastern Europe. Few large nationally representative studies
have specifically addressed the issue of MDR-TB in migrant popu-
lations in EU/EEA countries. Most available data are from hospital-
based studies reporting data by country of origin. The majority of
foreign-born patients with MDR-TB in the EU/EEA are from the
former Soviet Union (FSU). In Germany, of the 184 MDR-TB
patients identified through the network of hospitals participating
in the Tuberculosis Network European Trials group, 80.2% were
from FSU.30 In Finland, among all culture-verified incident MDR-
TB cases diagnosed between 1994 and 2005; 73.7% were of foreign
origin, mainly from Russia and Estonia.10,31
HIV co-infection by origin of cases
Our analysis of TESSy data found that HIV status was unknown in
97% of foreign-born and 89% of native TB cases for the 2000-10
period. In 2010, HIV status was known in 27% of native and 4.7% of
foreign-born cases. A 2011 survey attempted to assess current
practices for monitoring HIV-TB co-infection in the EU/EEA.32
Eighteen out of 25 EU/EEA countries that responded reported
collecting HIV status on individual TB cases. Of them, 10
countries reported having targeted programmes for TB testing for
migrants in general, whereas four reported having targeted
programmes for TB testing for asylum seekers, non-European
migrants and Roma.32
In 2010, EU/EEA aggregated data showed that among the 17 650
TB cases with known HIV status, 6.0% (range: 0–17.6%) were HIV
positive.11 From our TESSy analysis, very limited case-based data on
both HIV status and migrant status were available to allow for a
disaggregated analysis. Thus, between 2000 and 2010, only 0.48% of
native and 0.25% of foreign-born TB cases were notified as HIV
positive (figure 3). During this period, the proportion of migrants
with unknown HIV status was higher than the proportion in non-
migrants (97% vs. 89%). In 2010, HIV status was known in only
4.7% of migrant TB cases compared with 27% in native-born TB
cases.
Co-infection is especially common among certain marginalized
populations, such as homeless people, injecting drug users and the
subgroup of migrants. Foreign-born individuals represented >60%
of notified TB-HIV co-infected cases in Belgium, England and
Wales, France and the Netherlands (in England and Wales the
percentage exceeded 80%) while lower percentages, of 30%, were
reported in Italy and Spain.33 In Denmark, nearly 60% of TB-HIV
co-infected cases were migrants.
Paediatric TB by origin of cases
Between 2000 and 2009, 15.3% of paediatric TB cases notified in the
EU/EEA were of foreign origin. This value was 29.2% in low TB
incidence countries and 0.6% in high TB incidence countries.34
Overall, these percentages are lower than in the general population
data previously presented. In 2010, the percentage of paediatric TB
cases of foreign origin had increased to 19%.11 Only Norway,
Sweden and Austria reported a higher number of foreign-origin
TB cases than native-origin TB cases among children <15 years.10
Data on various aspects of TB in children are available from some
EU/EEA-Member States, including Sweden, Denmark, UK, Spain
and Greece.35–37 In Stockholm, 61% of laboratory-confirmed TB
cases among children notified between 2000 and 2009 were
from high TB burden countries and 25% were born in Sweden
but from parents from such countries.36 Similar figures were
reported from Denmark.37 In UK, 30% of TB cases notified
between 1999 and 2006 in people aged <16 years were born
outside UK.35 In London, the figure was higher (47.6%)38; the
most common countries of origin were Somalia, Pakistan, India,
Zimbabwe and Philippines. TB notification rates in children born
outside UK was 37.3/100 000 (compared with 2.5/100 000 UK-born
children). In Spain, the percentage of foreign-born subjects among
paediatric TB cases increased from 2% in 1978-87, to 6% in 1988-97
and 46% in 1998-2007.39 Extra-pulmonary TB has been reported as
more frequent among paediatric TB cases of foreign origin in some
Figure 2 TB case reports and notification rates by place of birth, UK, 2000-09. Source: Health Protection Agency. Enhanced TB surveillance.
Demography—TB trends by place of birth, England
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settings37 but not in others.35 As clinical symptoms of disseminated
and extra-pulmonary TB forms may be less specific, this can
negatively impact diagnostic delay among children.40 Furthermore,
laboratory and radiological diagnosis can be challenging in the
paediatric population. As a consequence, TB in children is usually
identified though screening and active case finding (contact tracing)
rather than following clinical manifestations. Children from high TB
countries are at risk of acquiring infection before arrival in the host
country.36 In UK, the median period between arrival in UK and TB
diagnosis in migrant children is 2 years. Data from Spain and
Denmark showed that when TB is acquired in the host country,
most transmission occurs within the household37,39; however, in
recent years, in these countries and in Sweden, index cases are in-
creasingly being identified among friends and people in charge of
taking care of children.36,39
Discussion
To our knowledge, this is the first study to use multiple sources of
data—including the largest available European database on
infectious disease notifications—to assess the burden and specific
features of TB in migrant populations in the EU/EEA.
Overall, in the EU/EEA, the share of foreign-born subjects
among notified TB cases is increasing; this percentage is higher in
Scandinavian and Northern EU/EEA countries and lower in Eastern
EU/EEA settings. This relative rise of TB cases in foreign-born individ-
uals is due to both a real increase, as well as attributable to the sizeable
drop in native cases in certain countries.2 In addition, an increase in the
absolute number of TB cases should be interpreted in the context of the
global migration flows between different countries (Supplementary
table S1). TB incidence rates are higher in foreign-born populations
as compared with native populations. However, it is important to note
that interpretation of TB incidence rates in migrants remains
challenging.5 Unfortunately, migration statistics do not include
irregular migrants and thus denominators may be underestimated.
Moreover, as ECDC does not have access to migrants’ denominators
figures (neither total, nor country of origin-specific denominators)
surveillance data reported by the ECDC do not include incidence
rates by geographical origin of cases.10
The country of origin of migrants might also impact on the TB
burden in selected settings. For example, the UK, in contrast to other
countries with high immigration rates, hosts many migrants from
high TB burden countries (10% of migrants in the UK come from
countries with a TB incidence 250/100 000) which may explain the
increasing trends in TB incidence reported in the country. In other
countries that have experienced progressively decreasing TB notifi-
cation rates, such as Germany, Italy and Spain, the greatest share of
migrants come from countries with relatively low TB incidence.
Foreign-born TB cases are younger when compared with native
cases. This is mainly due to the different age structure of migrant
and native populations in EU/EEA, but might also be linked to the
different natural history of TB in the two populations.
No clear pattern emerged when analysing TB transmission by
origin of case. It is likely that the disease develops through different
pathways in foreign-born and native subjects. For migrants, clinical
disease can come about through reactivation of infection acquired in
the country of origin or through recent infection acquired in the host
country. Furthermore, in some cases, infection in migrants is
acquired during visits to the home country. On the contrary, in
elderly native subjects, the disease may be more attributed to reacti-
vation of latent TB infection. No evidence was retrieved on TB trans-
mission between native citizens and migrants, and fears that the
presence of migrants might increase TB in native populations seem
to be unjustified.16,25 As mentioned earlier, the pathways through
which migrants are at higher risk for both TB infection transmission
and TB disease are difficult to disentangle. To determine which risk
factors are associated with TB among migrant populations would
require detailed studies in every country using individual level data,
for example a series of case control studies, which is beyond the scope
of the current study.
Migrants are more frequently reported to have extra-pulmonary
TB than the native population. No clear pattern emerged on drug
resistance by migrant status, although MDR-TB is most frequently
reported in migrants originating from high MDR-TB burden
settings. There is however a need to get a better understanding of
drug-resistant TB among migrants. Reporting completeness of HIV
status among TB cases is too low to derive meaningful conclusions,
and improvements need to be made to collect better data on HIV
status for both the native and migrant populations.
With regard to TB in children, foreign-born children account for
a lower proportion among all paediatric TB cases (15.3%), when
compared with the percentages of foreign-born reported in the
overall population (26%).14 However, data on paediatric TB by
origin of cases should be interpreted with caution, as surveillance
data in most countries do not distinguish between children born in
the host country of foreign-born parents from those born of native
parents. This is a matter for concern because children of migrants
may experience similar social, behavioural and environmental risk
factors as foreign-born populations.34
Our study has limitations. These are mainly due to the hetero-
geneity of original studies in terms of study setting, study popula-
tions, data collected, methods applied and exposure and outcomes
assessment which limited the potential of pooling estimates and
findings. Moreover, the lack of data on denominators is a main
limitation when assessing the burden of TB in migrant populations,
as incidence estimates are often unreliable and tend to bias towards
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Figure 3 Co-infection of TB and HIV, by migration status—EU/EEA 2007-10 (TESSy analysis)
Tuberculosis among migrant populations in Europe 5 of 7
overestimations. In addition, only papers published in English were
included in the literature review, which may limit the number of
studies included from EU/EEA-Member States that do not routinely
publish in English.
Available data on TB burden in migrant populations in Europe is
incomplete, partly due to inconsistent surveillance and reporting
systems in place in different countries and to the difficulties of
properly tracing migrants in denominators when estimating
incidence rates and trends. However, the collection and analysis of
TB surveillance data in Europe since 2008 by the ECDC and WHO/
EURO is an important step towards harmonization of national sur-
veillance systems and data sharing. The TB case definition is applied
consistently by EU/EEA-Member States in their surveillance systems
and much relevant information on migration status is collected. In
2010, 29 EU/EEA countries reported data on the geographical origin
of TB cases, with data completeness of 97.5%.
The efforts taken in recent years to strengthen and harmonize TB
surveillance systems in the EU/EEA and capture migrant-specific
information have led to a greater understanding of the association
between migration and TB. Nevertheless, additional steps are still
needed to strengthen national surveillance systems by harmonizing
and improving data completeness. In addition, better data are
needed on the extent to which health determinants and living
conditions in the host country influence migrants’ vulnerability to
TB. This information is of fundamental importance to better plan,
implement and evaluate targeted TB prevention and control inter-
ventions in the EU/EEA. Priority must be given to addressing
migrant health and ensuring that all individuals have access to
prompt, high-quality TB care.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 Migrant populations in the EU/EEA are at higher risk of
tuberculosis infection and disease when compared with
native-born populations. Among them, subgroups from
high-TB burden countries are at greatest risk;
 The share of foreign-born cases (by country of birth or citi-
zenship) among notified tuberculosis cases in the EU/EEA is
25%—ranging from 0.2% in Romania to 85.8% in
Sweden—and has been increasing in the last decades;
 Foreign-born tuberculosis cases share different
socioeconomic and clinical features when compared with
native cases;
 Although the collection and analysis of tuberculosis surveil-
lance data in Europe has been recently harmonized, available
data on the tuberculosis burden in migrant populations in
Europe is incomplete;
 Tuberculosis prevention and control programmes in the EU/
EEA should target vulnerable populations, including
migrants
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